Simner P, Pitout J, Dingle T
Clin Microbiol Rev. 2024; 37(4):e0005422.
PMID: 39545731
PMC: 11629623.
DOI: 10.1128/cmr.00054-22.
Moreira da Silva J, Menezes J, Marques C, Pomba C
Antibiotics (Basel). 2022; 11(4).
PMID: 35453284
PMC: 9032395.
DOI: 10.3390/antibiotics11040533.
Gajic I, Kabic J, Kekic D, Jovicevic M, Milenkovic M, Culafic D
Antibiotics (Basel). 2022; 11(4).
PMID: 35453179
PMC: 9024665.
DOI: 10.3390/antibiotics11040427.
Noster J, Thelen P, Hamprecht A
Antibiotics (Basel). 2021; 10(9).
PMID: 34572722
PMC: 8465816.
DOI: 10.3390/antibiotics10091140.
Brazelton de Cardenas J, Garner C, Su Y, Tang L, Hayden R
J Clin Microbiol. 2021; 59(11):e0103321.
PMID: 34406800
PMC: 8525580.
DOI: 10.1128/JCM.01033-21.
Accuracy of Broad-Panel PCR-Based Bacterial Identification for Blood Cultures in a Pediatric Oncology Population.
Garner C, Brazelton de Cardenas J, Suganda S, Hayden R
Microbiol Spectr. 2021; 9(1):e0022121.
PMID: 34232100
PMC: 8552719.
DOI: 10.1128/Spectrum.00221-21.
Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases.
Jonas D, Reuter S, Klassen S, Weber S, Buck M, Giani T
Sci Rep. 2021; 11(1):13150.
PMID: 34162904
PMC: 8222379.
DOI: 10.1038/s41598-021-92336-3.
A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options.
Elshamy A, Aboshanab K
Future Sci OA. 2020; 6(3):FSO438.
PMID: 32140243
PMC: 7050608.
DOI: 10.2144/fsoa-2019-0098.
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria.
Nordmann P, Poirel L
Clin Infect Dis. 2019; 69(Suppl 7):S521-S528.
PMID: 31724045
PMC: 6853758.
DOI: 10.1093/cid/ciz824.
The Global Ascendency of OXA-48-Type Carbapenemases.
Pitout J, Peirano G, Kock M, Strydom K, Matsumura Y
Clin Microbiol Rev. 2019; 33(1).
PMID: 31722889
PMC: 6860007.
DOI: 10.1128/CMR.00102-19.
Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.
Fleischmann W, Greenwood-Quaintance K, Patel R
Antimicrob Agents Chemother. 2019; 64(2).
PMID: 31712206
PMC: 6985721.
DOI: 10.1128/AAC.01711-19.
Decline in AmpC β-lactamase-producing Escherichia coli in a Dutch teaching hospital (2013-2016).
den Drijver E, Verweij J, Verhulst C, Oome S, Soer J, Willemsen I
PLoS One. 2018; 13(10):e0204864.
PMID: 30273375
PMC: 6166941.
DOI: 10.1371/journal.pone.0204864.
A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults.
Logan L, Nguyen D, Scaggs Huang F, Qureshi N, Charnot-Katsikas A, Bartlett A
Pediatr Infect Dis J. 2018; 38(5):490-495.
PMID: 30169484
PMC: 6395555.
DOI: 10.1097/INF.0000000000002176.
Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli.
Schmidt-Malan S, Mishra A, Mushtaq A, Brinkman C, Patel R
Antimicrob Agents Chemother. 2018; 62(8).
PMID: 29760145
PMC: 6105828.
DOI: 10.1128/AAC.00533-18.
Evaluation of a New Commercial Microarray Platform for the Simultaneous Detection of β-Lactamase and and Genes in Enterobacteriaceae.
Bernasconi O, Principe L, Tinguely R, Karczmarek A, Perreten V, Luzzaro F
J Clin Microbiol. 2017; 55(10):3138-3141.
PMID: 28768732
PMC: 5625400.
DOI: 10.1128/JCM.01056-17.
Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey.
Logan L, Hujer A, Marshall S, Domitrovic T, Rudin S, Zheng X
Antimicrob Agents Chemother. 2016; 60(6):3462-9.
PMID: 27021322
PMC: 4879402.
DOI: 10.1128/AAC.00098-16.